Hayek Kallen Investment Management Pfizer Inc Transaction History

Hayek Kallen Investment Management

$282 Million
Q3 2024

A detailed history of Hayek Kallen Investment Management transactions in Pfizer Inc stock. As of the latest transaction made, Hayek Kallen Investment Management holds 106,580 shares of PFE stock, worth $2.92 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

106,580

Previous 106,914 0.31%

Holding current value

$2.92 Million

Previous $2.99 Million 3.11%

% of portfolio

1.09%

Previous 1.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $9,251 - $10,484	-334 Reduced 0.31%	106,580 $3.08 Million
Q2 2024 Jul 18, 2024	SELL	$25.26 - $29.6 $12,781 - $14,977	-506 Reduced 0.47%	106,914 $2.99 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $100,271 - $115,144	3,873 Added 3.74%	107,420 $2.98 Million
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $35,406 - $45,988	1,355 Added 1.33%	103,547 $2.98 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $21,339 - $24,944	665 Added 0.65%	102,192 $3.39 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $101,605 - $117,555	2,813 Added 2.85%	101,527 $3.72 Million
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $90,518 - $117,841	-2,298 Reduced 2.27%	98,714 $4.03 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $98,530 - $128,620	-2,360 Reduced 2.28%	101,012 $5.18 Million
Q3 2022 Oct 19, 2022	SELL	$43.76 - $53.42 $350 - $427	-8 Reduced 0.01%	103,372 $4.52 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $7,910 - $9,378	-170 Reduced 0.16%	103,380 $5.42 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $5,581 - $6,916	-122 Reduced 0.12%	103,550 $5.36 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $28,056 - $41,588	-679 Reduced 0.65%	103,672 $6.12 Million
Q3 2021 Oct 06, 2021	SELL	$39.25 - $50.42 $22,058 - $28,336	-562 Reduced 0.54%	104,351 $4.49 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $14,076 - $15,946	392 Added 0.38%	104,913 $4.11 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $12,190 - $13,748	364 Added 0.35%	104,521 $3.79 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $14,559 - $18,513	435 Added 0.42%	104,157 $3.83 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $730 - $856	23 Added 0.02%	103,722 $3.81 Million
Q2 2020 Sep 10, 2020	BUY	$30.12 - $36.54 $79,787 - $96,794	2,649 Added 2.62%	103,699 $3.39 Million
Q1 2020 Apr 22, 2020	BUY	$27.03 - $38.62 $5,865 - $8,380	217 Added 0.22%	101,050 $3.3 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $78,876 - $89,514	2,396 Added 2.43%	100,833 $3.95 Million
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $38,305 - $49,671	1,179 Added 1.21%	98,437 $3.54 Million
Q2 2019 Jul 17, 2019	BUY	$36.98 - $41.52 $11,389 - $12,788	308 Added 0.32%	97,258 $4.21 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $29,887 - $32,836	797 Added 0.83%	96,950 $4.12 Million
Q4 2018 Jan 16, 2019	SELL	$38.47 - $43.86 $16,311 - $18,596	-424 Reduced 0.44%	96,153 $4.2 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $77,660 - $94,197	-2,253 Reduced 2.28%	96,577 $4.26 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $61,563 - $74,672	1,786 Added 1.84%	98,830 $3.51 Million
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $58,902 - $62,795	-1,786 Reduced 1.81%	97,044 $3.52 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $75,116 - $87,145	-2,354 Reduced 2.33%	98,830 $3.51 Million
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $66,653 - $70,721	-2,004 Reduced 1.94%	101,184 $3.66 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $3.2 Million - $3.52 Million	103,188	103,188 $3.68 Million

Others Institutions Holding PFE

# of Institutions

3,245

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Account

Hayek Kallen Investment Management Pfizer Inc Transaction History